Edwards Lifesciences

Global specialist in the science of heart values and hemodynamic monitoring.

Launch date

1958

Employees

Market cap

Enterprise valuation

€36.1b (Public information from Sep 2024)

Irvine California (HQ)

http://www.edwards.com

https://twitter.com/edwardslifesci https://www.facebook.com/pages/Edwards-Lifesciences/143318615703224 https://www.linkedin.com/company/edwards-lifesciences

View job openings

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	4.4b	5.2b	5.4b	6.0b	6.5b	7.0b	7.7b
% growth	1 %	19 %	3 %	12 %	8 %	9 %	9 %
EBITDA	1.7b	1.5b	1.8b	1.9b	2.0b	2.2b	2.5b
% EBITDA margin	40 %	28 %	34 %	32 %	31 %	32 %	32 %
Profit	823m	1.5b	1.5b	1.4b	1.5b	1.8b	2.0b
% profit margin	19 %	29 %	28 %	23 %	24 %	25 %	25 %
EV / revenue	12.8x	15.4x	8.5x	7.5x	6.3x	5.6x	5.1x
EV / EBITDA	32.4x	54.4x	25.1x	23.2x	20.1x	17.7x	15.7x
R&D budget	761m	903m	945m	1.1b	-	-	-
R&D % of revenue	17 %	17 %	18 %	18 %	-	-	-

Date	Investors	Amount	Round
-	Earlybird Venture Capital TIIN Capital	N/A	-
Apr 2000	N/A	N/A	IPO
Jan 2018	N/A	N/A	IPO
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.

By Country

United States 12 Israel 3 Netherlands 1 United Kingdom 1 Singapore 1

By Industry

Health 15 Marketing 1 Semiconductors 1

By Round

ACQUISITION 11 LATE VC 3 SERIES B 2 SERIES F 1 SERIES A 1 SERIES C 1 SERIES E 1 SERIES D 1

ACQUISITION by Edwards Lifesciences Oct 2012

ACQUISITION by Edwards Lifesciences Nov 2016

BUYOUT by BC Partners Jul 2021

JenaValve Technology

ACQUISITION by Edwards Lifesciences Jul 2024

Embrella Cardiovascular

ACQUISITION by Edwards Lifesciences Mar 2011

CardiAQ Valve Technologies

ACQUISITION by Edwards Lifesciences Jul 2015

ACQUISITION by Edwards Lifesciences Jul 2024

Middle Peak Medical

ACQUISITION by Symetis Feb 2017

ACQUISITION by Johnson & Johnson Aug 2024